CompletedNCT00005512
Genetic Epidemiology--Development of Cardiovascular Risk
Studying Genetic obesity
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Virginia Commonwealth University
- Principal Investigator
- Hermine MaesVirginia Commonwealth University
- Eligibility
- 10-18 years · All sexes
- Timeline
- 1998 – 2002
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00005512 on ClinicalTrials.govOther trials for Genetic obesity
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07296900International Genetic Obesity RegistryUniversity of Ulm
- RECRUITINGNANCT06978504Impact of Genetic Polymorphisms And DASH Diet On Weight Loss Progression In Climacteric Women With Metabolic SyndromeNutrindo Ideais Research Center
- RECRUITINGNCT06694012Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2Osaka Metropolitan University
- RECRUITINGNANCT06380426Real-life Evaluation of WEGOVY (Semaglutide) Treatment in Adults With Monogenic Obesity (ObGeSema)Assistance Publique - Hôpitaux de Paris
- RECRUITINGNANCT06534541Genetic Risk, Parental Feeding Practices, and Appetitive Traits in Early LifeTrustees of Dartmouth College
- RECRUITINGNANCT05963971A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk FactorsColumbia University
- ACTIVE NOT RECRUITINGNCT06618430Evaluation Of DNA Methylation Pattern In Healthy, Sarcopenic, Obese And Sarcopenic Obese Older Women: A Cross-Sectional StudyUniversity of Sao Paulo
- RECRUITINGPHASE4NCT05919797Weight Loss Study: Genetics and Response to Naltrexone/BupropionColumbia University